133 related articles for article (PubMed ID: 8058610)
1. Oral absorption of peptides: the effect of absorption site and enzyme inhibition on the systemic availability of metkephamid.
Langguth P; Merkle HP; Amidon GL
Pharm Res; 1994 Apr; 11(4):528-35. PubMed ID: 8058610
[TBL] [Abstract][Full Text] [Related]
2. Colonic absorption and bioavailability of the pentapeptide metkephamid in the rat.
Langguth P; Breves G; Stöckli A; Merkle HP; Wolffram S
Pharm Res; 1994 Nov; 11(11):1640-5. PubMed ID: 7870683
[TBL] [Abstract][Full Text] [Related]
3. Metabolism and transport of the pentapeptide metkephamid by brush-border membrane vesicles of rat intestine.
Langguth P; Bohner V; Biber J; Merkle HP
J Pharm Pharmacol; 1994 Jan; 46(1):34-40. PubMed ID: 8201526
[TBL] [Abstract][Full Text] [Related]
4. First-pass metabolism of peptide drugs in rat perfused liver.
Taki Y; Sakane T; Nadai T; Sezaki H; Amidon GL; Langguth P; Yamashita S
J Pharm Pharmacol; 1998 Sep; 50(9):1013-8. PubMed ID: 9811162
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal absorption of peptide drug: quantitative evaluation of the degradation and the permeation of metkephamid in rat small intestine.
Taki Y; Sakane T; Nadai T; Sezaki H; Amidon GL; Langguth P; Yamashita S
J Pharmacol Exp Ther; 1995 Jul; 274(1):373-7. PubMed ID: 7616421
[TBL] [Abstract][Full Text] [Related]
6. Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model.
Cao X; Gibbs ST; Fang L; Miller HA; Landowski CP; Shin HC; Lennernas H; Zhong Y; Amidon GL; Yu LX; Sun D
Pharm Res; 2006 Aug; 23(8):1675-86. PubMed ID: 16841194
[TBL] [Abstract][Full Text] [Related]
7. Intestinal metabolism and absorption of cholecystokinin analogs in rats.
Su SF; Amidon GL; Lee HJ
Biochem Biophys Res Commun; 2002 Apr; 292(3):632-8. PubMed ID: 11922613
[TBL] [Abstract][Full Text] [Related]
8. Presystemic metabolism and intestinal absorption of antipsoriatic fumaric acid esters.
Werdenberg D; Joshi R; Wolffram S; Merkle HP; Langguth P
Biopharm Drug Dispos; 2003 Sep; 24(6):259-73. PubMed ID: 12973823
[TBL] [Abstract][Full Text] [Related]
9. Intestinal absorption and activation of decitabine amino acid ester prodrugs mediated by peptide transporter PEPT1 and enterocyte enzymes.
Tao W; Zhao D; Sun M; Wang Z; Lin B; Bao Y; Li Y; He Z; Sun Y; Sun J
Int J Pharm; 2018 Apr; 541(1-2):64-71. PubMed ID: 29471144
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of absorption and bioavailability of echinacoside by verapamil or clove oil.
Shen JY; Yang XL; Yang ZL; Kou JP; Li F
Drug Des Devel Ther; 2015; 9():4685-93. PubMed ID: 26316707
[TBL] [Abstract][Full Text] [Related]
11. Comparison of site-dependent degradation of peptide drugs within the gut of rats and rabbits.
Bai JP; Chang LL
J Pharm Pharmacol; 1993 Dec; 45(12):1085-7. PubMed ID: 7908979
[TBL] [Abstract][Full Text] [Related]
12. Optimization of the local inhibition of intestinal adenosine deaminase (ADA) by erythro-9-(2-hydroxy-3-nonyl)adenine: enhanced oral delivery of an ADA-activated prodrug for anti-HIV therapy.
Singhal D; Anderson BD
J Pharm Sci; 1998 May; 87(5):578-85. PubMed ID: 9572908
[TBL] [Abstract][Full Text] [Related]
13. Structure-permeation relations of met-enkephalin peptide analogues on absorption and secretion mechanisms in Caco-2 monolayers.
Lang VB; Langguth P; Ottiger C; Wunderli-Allenspach H; Rognan D; Rothen-Rutishauser B; Perriard JC; Lang S; Biber J; Merkle HP
J Pharm Sci; 1997 Jul; 86(7):846-53. PubMed ID: 9232527
[TBL] [Abstract][Full Text] [Related]
14. Enhanced oral bioavailability of 2'- beta-fluoro-2',3'-dideoxyadenosine (F-ddA) through local inhibition of intestinal adenosine deaminase.
DeGraw RT; Anderson BD
Pharm Res; 2001 Sep; 18(9):1270-6. PubMed ID: 11683239
[TBL] [Abstract][Full Text] [Related]
15. SCFA increase intestinal Na absorption by induction of NHE3 in rat colon and human intestinal C2/bbe cells.
Musch MW; Bookstein C; Xie Y; Sellin JH; Chang EB
Am J Physiol Gastrointest Liver Physiol; 2001 Apr; 280(4):G687-93. PubMed ID: 11254495
[TBL] [Abstract][Full Text] [Related]
16. Distribution of brush-border membrane peptidases along the rat intestine.
Bai JP
Pharm Res; 1994 Jun; 11(6):897-900. PubMed ID: 7937532
[TBL] [Abstract][Full Text] [Related]
17. Role of rat intestinal brush-border membrane angiotensin-converting enzyme in dietary protein digestion.
Yoshioka M; Erickson RH; Woodley JF; Gulli R; Guan D; Kim YS
Am J Physiol; 1987 Dec; 253(6 Pt 1):G781-6. PubMed ID: 2827504
[TBL] [Abstract][Full Text] [Related]
18. Oral absorption of peptides: influence of pH and inhibitors on the intestinal hydrolysis of leu-enkephalin and analogues.
Friedman DI; Amidon GL
Pharm Res; 1991 Jan; 8(1):93-6. PubMed ID: 2014216
[TBL] [Abstract][Full Text] [Related]
19. Influences of regional differences in activities of brush-border membrane peptidases within the rat intestine on site-dependent stability of peptide drugs.
Bai JP
Life Sci; 1993; 53(15):1193-201. PubMed ID: 8412476
[TBL] [Abstract][Full Text] [Related]
20. Intestinal permeability of forskolin by in situ single pass perfusion in rats.
Liu ZJ; Jiang DB; Tian LL; Yin JJ; Huang JM; Weng WY
Planta Med; 2012 May; 78(7):698-702. PubMed ID: 22411728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
